Sonoma Allocations’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Sonoma Allocations's LLY Position: Q2 2026 in Review
Sonoma Allocations reduced its Eli Lilly (LLY) stake by 6.3% in Q2 2026, selling an estimated $84.8K and leaving 1,225 shares worth $1.46M. The position accounts for 0.45% of the portfolio, ranked #38.
Sonoma Allocations first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.52M in Q4 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Sonoma Allocations held 1,225 shares of Eli Lilly worth $1.46M as of Q2 2026.
- Sonoma Allocations sold 83 Eli Lilly shares in Q2 2026, an estimated $84.8K.
- Eli Lilly made up 0.45% of Sonoma Allocations's portfolio in Q2 2026, its #38 holding.
- Sonoma Allocations first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
- Sonoma Allocations's Eli Lilly position peaked at $1.52M in Q4 2025.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Sonoma Allocations's 13F filing for Q2 2026, filed 8 Jul 2026.